SILVER SPRING, Md. (AP) — SILVER SPRING, Md. (AP) — United Therapeutics Corp. (UTHR) on Wednesday reported fourth-quarter net income of $301.3 million.
The Silver Spring, Maryland-based company said it had profit of $6.19 per share.
The results surpassed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $6.10 per share.
The drugmaker posted revenue of $735.9 million in the period, also surpassing Street forecasts. Seven analysts surveyed by Zacks expected $725.3 million.
For the year, the company reported profit of $1.2 billion, or $24.64 per share. Revenue was reported as $2.88 billion.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on UTHR at https://www.zacks.com/ap/UTHR
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
